362 - Genomic profiling of patients with metastatic castration-resistant prostate cancer (mCRPC) for the evaluation of rucaparib: Next-generation sequencing (NGS) of tumour tissue and cell-free DNA (cfDNA).

Autor: Piulats, J.M. (AUTHOR), Abida, W. (AUTHOR), McDermott, R. (AUTHOR), Shapiro, J.D. (AUTHOR), Ostler, P. (AUTHOR), Reaume, M.N. (AUTHOR), Mejlholm, I. (AUTHOR), Byard, I. (AUTHOR), Hussain, A. (AUTHOR), Morris, D. (AUTHOR), Campbell, D. (AUTHOR), Burke, J. (AUTHOR), Laguerre, B. (AUTHOR), Reid, A. (AUTHOR), Voog, E. (AUTHOR), Benjelloun, A. (AUTHOR), Spaeth, D. (AUTHOR), Goldfischer, E.R. (AUTHOR), Pintus, E. (AUTHOR), Loehr, A. (AUTHOR)
Zdroj: European Urology Supplements. Mar2019, Vol. 18 Issue 1, pe469-e470. 2p.
Databáze: Academic Search Ultimate
Externí odkaz: